Genesis Therapeutics logo

Genesis Therapeutics

Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.

4

Funding Rounds

$56.1m

Money raised

Overview

Pairing proven drug developers with the industry's most advanced small molecule discovery platform, to accelerate and optimize the development of new medicines.

Funding

Funding series

Funding Series Analysis

The company Genesis Therapeutics has raised a total of $4.1m in funding over 4 rounds.

Key Insights:

  • Genesis Therapeutics Seed round, November 2019: $4.1m
  • Genesis Therapeutics Series A round December 2020: $52m
Genesis Therapeutics logo
Genesis Therapeutics Seed round, November 2019 $4.1m
Genesis Therapeutics logo
Genesis Therapeutics Series A round December 2020 $52m

Industries

Genesis Therapeutics is active in the following industries:
  • Technology
  • Biology
  • Biotechnology
  • Healthcare
  • Analytics
  • Engineering
  • Drug discovery
  • Predictive analytics
  • Artificial Intelligence (AI)
  • Biomedical engineering